Jill M. Broadfoot
Overview
Jill M. Broadfoot received an average of $666K in total compensation, including $345K in salary, at aTYR PHARMA from 2018 to 2023. Jill Broadfoot also received an average of $679K at Vical from 2006 to 2012.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2012
- 2011
- 2010
- 2009
aTYR PHARMAChief Financial Officer
aTYR PHARMAChief Financial Officer
aTYR PHARMAChief Financial Officer
aTYR PHARMAChief Financial Officer
aTYR PHARMAChief Financial Officer
aTYR PHARMAChief Financial Officer
VicalSenior Vice President, Chief Financial Officer and Secretary
VicalSenior Vice President, Chief Financial Officer and Secretary
VicalSenior Vice President, Chief Financial Officer and Secretary
VicalSenior Vice President, Chief Financial Officer and Secretary
Source: SEC filings on April 5, 2024, March 22, 2022, March 23, 2021, April 2, 2020, March 28, 2019, April 10, 2013, April 13, 2012, and April 14, 2010.
Related executives
We found 15 more executives who work or worked at aTYR PHARMA and Vical.
Sanjay Shukla
aTYR PHARMA
Chief Executive Officer
Nancy Denyes
aTYR PHARMA
General Counsel
Ashraf Amanullah
aTYR PHARMA
Former Senior Vice President, Biologics, Development and Manufacturing
David King
aTYR PHARMA
Chief Scientific Officer
John Mendlein
aTYR PHARMA
Chief Executive Officer
Sanuj Ravindran
aTYR PHARMA
Former Chief Business Officer
Vijay Samant
Vical
Chief Executive Officer
Mammen Mammen
Vical
Sr. Vice President, Clinical Development
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019